Funder: Military Health System Research Program
Due Dates (Anticipated): June 2026 (Letter of Intent) | September 2026 (Full Application)
Funding Amounts: Up to $1.015 million total costs over a maximum of 3 years per award.
Summary: Supports research to improve quality of life, function, and survivorship for melanoma patients, requiring survivor or advocate involvement and allowing clinical trials.
Key Information: Clinical trials are allowed; a melanoma survivor or patient advocate must be part of the research team.